{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:31:38Z","timestamp":1793316698760,"version":"4.5.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02639-x","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T17:49:04Z","timestamp":1753984144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vitamin D immune modulation of the anti-inflammatory effects of HDL-associated proteins"],"prefix":"10.1186","volume":"24","author":[{"given":"Hanaa","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu M.","family":"Zughaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"3","key":"2639_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266\u201381.","journal-title":"N Engl J Med"},{"issue":"1","key":"2639_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0888-7543(91)90114-T","volume":"11","author":"J Szpirer","year":"1991","unstructured":"Szpirer J, Szpirer C, Riviere M, Levan G, Marynen P, Cassiman J-J, et al. The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics. 1991;11(1):168\u201373.","journal-title":"Genomics"},{"issue":"1","key":"2639_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/jc.2008-1454","volume":"94","author":"D Bikle","year":"2009","unstructured":"Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94(1):26\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2639_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1210\/er.2004-0002","volume":"26","author":"S Nagpal","year":"2005","unstructured":"Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662\u201387.","journal-title":"Endocr Rev"},{"issue":"1","key":"2639_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11154-011-9198-9","volume":"13","author":"JW Pike","year":"2012","unstructured":"Pike JW, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor: an update on mechanisms. Reviews Endocr Metabolic Disorders. 2012;13(1):45\u201355.","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"7","key":"2639_CR6","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2639_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881\u20136.","journal-title":"J Investig Med"},{"issue":"11","key":"2639_CR8","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.4049\/jimmunol.160.11.5314","volume":"160","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT, Woodward WD, Hayes CE, DeLuca HF. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998;160(11):5314\u20139.","journal-title":"J Immunol"},{"key":"2639_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2016.05.024","volume":"85","author":"D Ragab","year":"2016","unstructured":"Ragab D, Soliman D, Samaha D, Yassin A. Vitamin D status and its modulatory effect on interferon gamma and interleukin-10 production by peripheral blood mononuclear cells in culture. Cytokine. 2016;85:5\u201310.","journal-title":"Cytokine"},{"issue":"4","key":"2639_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/eci.10.31","volume":"6","author":"M Verway","year":"2010","unstructured":"Verway M, Behr MA, White JH, Vitamin D. NOD2, autophagy and crohn\u2019s disease. Expert Rev Clin Immunol. 2010;6(4):505\u20138.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"2639_CR11","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","volume":"173","author":"TT Wang","year":"2004","unstructured":"Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909\u201312.","journal-title":"J Immunol"},{"issue":"2","key":"2639_CR12","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.4110\/in.2020.20.e12","volume":"20","author":"C Chung","year":"2020","unstructured":"Chung C, Silwal P, Kim I, Modlin RL, Jo EK. Vitamin D-Cathelicidin axis: at the crossroads between protective immunity and pathological inflammation during infection. Immune Netw. 2020;20(2):e12.","journal-title":"Immune Netw"},{"issue":"3","key":"2639_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.chom.2009.08.004","volume":"6","author":"JM Yuk","year":"2009","unstructured":"Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3 induces autophagy in human monocytes\/macrophages via Cathelicidin. Cell Host Microbe. 2009;6(3):231\u201343.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"2639_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/15548627.2016.1140293","volume":"12","author":"JM Park","year":"2016","unstructured":"Park JM, Jung CH, Seo M, Otto NM, Grunwald D, Kim KH, et al. The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy. 2016;12(3):547\u201364.","journal-title":"Autophagy"},{"issue":"1","key":"2639_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2010.07.002","volume":"134","author":"U Ikeda","year":"2010","unstructured":"Ikeda U, Wakita D, Ohkuri T, Chamoto K, Kitamura H, Iwakura Y, et al. 1\u03b1,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett. 2010;134(1):7\u201316.","journal-title":"Immunol Lett"},{"issue":"17","key":"2639_CR16","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/MCB.05020-11","volume":"31","author":"S Joshi","year":"2011","unstructured":"Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011;31(17):3653\u201369.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2639_CR17","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/eji.201242370","volume":"42","author":"Z Urry","year":"2012","unstructured":"Urry Z, Chambers ES, Xystrakis E, Dimeloe S, Richards DF, Gabry\u0161ov\u00e1 L, et al. The role of 1\u03b1,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3\u2009+\u2009and IL-10\u2009+\u2009CD4\u2009+\u2009T cells. Eur J Immunol. 2012;42(10):2697\u2013708.","journal-title":"Eur J Immunol"},{"key":"2639_CR18","doi-asserted-by":"crossref","unstructured":"Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, et al., editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US) et al. 2011. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK56070\/doi:10.17226\/13050","DOI":"10.17226\/13050"},{"key":"2639_CR19","doi-asserted-by":"crossref","unstructured":"Mousa H, Islam N, Ganji V, Zughaier SM. Serum 25-Hydroxyvitamin D is inversely associated with monocyte percentage to HDL cholesterol ratio among young healthy adults in Qatar. Nutrients [Internet]. 2021; 13(1).","DOI":"10.3390\/nu13010127"},{"key":"2639_CR20","doi-asserted-by":"crossref","unstructured":"Surdu AM, P\u00eenzariu O, Ciobanu D-M, Negru A-G, C\u0103inap S-S, Lazea C et al. Vitamin D and its role in the lipid metabolism and the development of atherosclerosis. Biomedicines [Internet] 2021; 9(2).","DOI":"10.3390\/biomedicines9020172"},{"issue":"8","key":"2639_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2362.2008.01977.x","volume":"38","author":"Y Talmor","year":"2008","unstructured":"Talmor Y, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest. 2008;38(8):548\u201354.","journal-title":"Eur J Clin Invest"},{"key":"2639_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsbmb.2016.12.016","volume":"175","author":"SJ Wimalawansa","year":"2018","unstructured":"Wimalawansa SJ. Vitamin D and cardiovascular diseases: causality. J Steroid Biochem Mol Biol. 2018;175:29\u201343.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2639_CR23","first-page":"e2741","volume":"10","author":"NR Parva","year":"2018","unstructured":"Parva NR, Tadepalli S, Singh P, Qian A, Joshi R, Kandala H, et al. Prevalence of vitamin D deficiency and associated risk factors in the US population (2011\u20132012). Cureus. 2018;10(6):e2741.","journal-title":"Cureus"},{"issue":"11","key":"2639_CR24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","volume":"168","author":"E Giovannucci","year":"2008","unstructured":"Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174\u201380.","journal-title":"Arch Intern Med"},{"issue":"12","key":"2639_CR25","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","volume":"168","author":"H Dobnig","year":"2008","unstructured":"Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340\u20139.","journal-title":"Arch Intern Med"},{"issue":"10","key":"2639_CR26","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1210\/jc.2008-0784","volume":"93","author":"S Pilz","year":"2008","unstructured":"Pilz S, M\u00e4rz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93(10):3927\u201335.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 2","key":"2639_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.34.4.897","volume":"34","author":"AC Borges","year":"1999","unstructured":"Borges AC, Feres T, Vianna LM, Paiva TB. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension. 1999;34(4 Pt 2):897\u2013901.","journal-title":"Hypertension"},{"key":"2639_CR28","doi-asserted-by":"crossref","unstructured":"Lei GS, Zhang C, Cheng BH, Lee CH. Mechanisms of action of vitamin D as supplemental therapy for Pneumocystis pneumonia. Antimicrob Agents Chemother. 2017;61(10).","DOI":"10.1128\/AAC.01226-17"},{"issue":"8","key":"2639_CR29","doi-asserted-by":"publisher","first-page":"e0136863","DOI":"10.1371\/journal.pone.0136863","volume":"10","author":"M Bozic","year":"2015","unstructured":"Bozic M, \u00c1lvarez \u00c1, de Pablo C, Sanchez-Ni\u00f1o MD, Ortiz A, Dolcet X, et al. Impaired vitamin D signaling in endothelial cell leads to an enhanced Leukocyte-Endothelium interplay: implications for atherosclerosis development. PLoS ONE. 2015;10(8):e0136863.","journal-title":"PLoS ONE"},{"key":"2639_CR30","volume-title":"Pharmacotherapy: A pathophysiologic approach, 11e","author":"DL Dixon","year":"2020","unstructured":"Dixon DL, Riche DM. Dyslipidemia. In: DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V, editors. Pharmacotherapy: A pathophysiologic approach, 11e. New York, NY: McGraw-Hill Education; 2020."},{"issue":"1","key":"2639_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12944-020-01204-y","volume":"19","author":"M Hedayatnia","year":"2020","unstructured":"Hedayatnia M, Asadi Z, Zare-Feyzabadi R, Yaghooti-Khorasani M, Ghazizadeh H, Ghaffarian-Zirak R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19(1):42.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"2639_CR32","first-page":"1129","volume":"37","author":"GJ Pearson","year":"2021","unstructured":"Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, et al. 2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021;37(8):1129\u201350.","journal-title":"Can J Cardiol"},{"issue":"1","key":"2639_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"4","key":"2639_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2217\/clp.12.46","volume":"7","author":"Q Qi","year":"2012","unstructured":"Qi Q, Qi L. Lipoprotein(a) and cardiovascular disease in diabetic patients. Clin Lipidol. 2012;7(4):397\u2013407.","journal-title":"Clin Lipidol"},{"key":"2639_CR35","doi-asserted-by":"publisher","first-page":"943162","DOI":"10.1155\/2014\/943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.","journal-title":"Cardiol Res Pract"},{"key":"2639_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.maturitas.2017.10.011","volume":"107","author":"EB Schmitt","year":"2018","unstructured":"Schmitt EB, Nahas-Neto J, Bueloni-Dias F, Poloni PF, Orsatti CL, Petri Nahas EA. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women. Maturitas. 2018;107:97\u2013102.","journal-title":"Maturitas"},{"issue":"4","key":"2639_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3177\/jnsv.62.213","volume":"62","author":"GT Pan","year":"2016","unstructured":"Pan GT, Guo JF, Mei SL, Zhang MX, Hu ZY, Zhong CK, et al. Vitamin D deficiency in relation to the risk of metabolic syndrome in Middle-Aged and elderly patients with type 2 diabetes mellitus. J Nutr Sci Vitaminol (Tokyo). 2016;62(4):213\u20139.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2639_CR38","doi-asserted-by":"publisher","first-page":"d1044","DOI":"10.2741\/1077","volume":"8","author":"S Lund-Katz","year":"2003","unstructured":"Lund-Katz S, Liu L, Thuahnai ST, Phillips MC. High density lipoprotein structure. Front Biosci. 2003;8:d1044\u201354.","journal-title":"Front Biosci"},{"key":"2639_CR39","unstructured":"Pirahanchi Y, Sinawe H, Dimri M, Biochemistry. LDL cholesterol. StatPearls. Treasure Island (FL): StatPearls publishing copyright \u00a9 2022. StatPearls Publishing LLC.; 2022."},{"key":"2639_CR40","unstructured":"Cox RA, Garc\u00eda-Palmieri MR. Cholesterol, triglycerides, and associated lipoproteins. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. Boston: Butterworths copyright \u00a9 1990. Butterworth Publishers, a division of Reed Publishing.; 1990."},{"issue":"3","key":"2639_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","volume":"1488","author":"T Hevonoja","year":"2000","unstructured":"Hevonoja T, Pentik\u00e4inen MO, Hyv\u00f6nen MT, Kovanen PT, Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: basis for Understanding molecular changes in modified LDL. Biochim Biophys Acta. 2000;1488(3):189\u2013210.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2639_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0022-2275(20)37628-8","volume":"37","author":"I Staprans","year":"1996","unstructured":"Staprans I, Rapp JH, Pan XM, Feingold KR. Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats. J Lipid Res. 1996;37(2):420\u201330.","journal-title":"J Lipid Res"},{"issue":"4","key":"2639_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10715762.2017.1319944","volume":"51","author":"M Ahotupa","year":"2017","unstructured":"Ahotupa M. Oxidized lipoprotein lipids and atherosclerosis. Free Radic Res. 2017;51(4):439\u201347.","journal-title":"Free Radic Res"},{"issue":"3","key":"2639_CR44","doi-asserted-by":"publisher","first-page":"e90497","DOI":"10.1371\/journal.pone.0090497","volume":"9","author":"W Hao","year":"2014","unstructured":"Hao W, Friedman A. The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model. PLoS ONE. 2014;9(3):e90497.","journal-title":"PLoS ONE"},{"issue":"11","key":"2639_CR45","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/CIRCRESAHA.114.301174","volume":"114","author":"GJ Randolph","year":"2014","unstructured":"Randolph GJ. Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res. 2014;114(11):1757\u201371.","journal-title":"Circ Res"},{"issue":"12","key":"2639_CR46","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.3390\/cimb46120807","volume":"46","author":"AK Fenercioglu","year":"2024","unstructured":"Fenercioglu AK. The Anti-Inflammatory roles of vitamin D for improving human health. Curr Issues Mol Biol. 2024;46(12):13514\u201325.","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"2639_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10565-022-09768-4","volume":"39","author":"C Zhu","year":"2023","unstructured":"Zhu C, Chen W, Cui H, Huang Z, Ding R, Li N, et al. TRIM64 promotes ox-LDL-induced foam cell formation, pyroptosis, and inflammation in THP-1-derived macrophages by activating a feedback loop with NF-\u03baB via I\u03baB\u03b1 ubiquitination. Cell Biol Toxicol. 2023;39(3):607\u201320.","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"2639_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejr.2011.07.004","volume":"33","author":"Y Ezzat","year":"2011","unstructured":"Ezzat Y, Sayed S, Gaber W, Mohey AM, Kassem TW. 25-Hydroxy vitamin D levels and its relation to disease activity and cardiovascular risk factors in women with systemic lupus erythematosus. Egypt Rheumatologist. 2011;33(4):195\u2013201.","journal-title":"Egypt Rheumatologist"},{"key":"2639_CR49","unstructured":"Feingold KR. Introduction to lipids and lipoproteins. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al. editors. Endotext. South Dartmouth (MA): mdtext.com, inc. Copyright \u00a9 2000\u20132022. MDText.com, Inc.; 2000."},{"issue":"11","key":"2639_CR50","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1210\/jc.2016-1500","volume":"101","author":"B Mittendorfer","year":"2016","unstructured":"Mittendorfer B, Yoshino M, Patterson BW, Klein S. VLDL triglyceride kinetics in lean, overweight, and obese men and women. J Clin Endocrinol Metab. 2016;101(11):4151\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2639_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jacl.2015.09.006","volume":"10","author":"JR Lupton","year":"2016","unstructured":"Lupton JR, Faridi KF, Martin SS, Sharma S, Kulkarni K, Jones SR, et al. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: the very large database of lipids (VLDL-3) study. J Clin Lipidol. 2016;10(1):72\u2013e811.","journal-title":"J Clin Lipidol"},{"issue":"28","key":"2639_CR52","doi-asserted-by":"publisher","first-page":"e3974","DOI":"10.1097\/MD.0000000000003974","volume":"95","author":"A Cai","year":"2016","unstructured":"Cai A, Li X, Zhong Q, Li M, Wang R, Liang Y, et al. Associations of high HDL cholesterol level with all-cause mortality in patients with heart failure complicating coronary heart disease. Med (Baltim). 2016;95(28):e3974.","journal-title":"Med (Baltim)"},{"issue":"29","key":"2639_CR53","doi-asserted-by":"publisher","first-page":"17805","DOI":"10.1016\/S0021-9258(18)38235-8","volume":"265","author":"JK Boyles","year":"1990","unstructured":"Boyles JK, Notterpek LM, Anderson LJ. Accumulation of Apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of Apolipoprotein D, Apolipoprotein A-IV, Apolipoprotein E, and Apolipoprotein A-I. J Biol Chem. 1990;265(29):17805\u201315.","journal-title":"J Biol Chem"},{"issue":"9","key":"2639_CR54","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1194\/jlr.M008086","volume":"51","author":"L Dai","year":"2010","unstructured":"Dai L, Datta G, Zhang Z, Gupta H, Patel R, Honavar J, et al. The Apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats. J Lipid Res. 2010;51(9):2695\u2013705.","journal-title":"J Lipid Res"},{"issue":"11","key":"2639_CR55","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1373\/clinchem.2014.228114","volume":"60","author":"PM Hutchins","year":"2014","unstructured":"Hutchins PM, Ronsein GE, Monette JS, Pamir N, Wimberger J, He Y, et al. Quantification of HDL particle concentration by calibrated ion mobility analysis. Clin Chem. 2014;60(11):1393\u2013401.","journal-title":"Clin Chem"},{"issue":"8","key":"2639_CR56","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","volume":"33","author":"JY Chien","year":"2005","unstructured":"Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688\u201393.","journal-title":"Crit Care Med"},{"issue":"2","key":"2639_CR57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI107758","volume":"54","author":"G Schonfeld","year":"1974","unstructured":"Schonfeld G, Pfleger B. The structure of human high density lipoprotein and the levels of Apolipoprotein A-I in plasma as determined by radioimmunoassay. J Clin Invest. 1974;54(2):236\u201346.","journal-title":"J Clin Invest"},{"key":"2639_CR58","doi-asserted-by":"crossref","unstructured":"Karan S, Mohapatra A, Sahoo PK, Garg LC, Dixit A. Structural-functional characterization of Recombinant Apolipoprotein A-I from Labeo rohita demonstrates heat-resistant antimicrobial activity. Appl Microbiol Biotechnol. 2019.","DOI":"10.1007\/s00253-019-10204-7"},{"issue":"16","key":"2639_CR59","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1021\/bi00337a028","volume":"24","author":"VI Zannis","year":"1985","unstructured":"Zannis VI, Cole FS, Jackson CL, Kurnit DM, Karathanasis SK. Distribution of Apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of Apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry. 1985;24(16):4450\u20135.","journal-title":"Biochemistry"},{"issue":"4","key":"2639_CR60","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0006-291X(02)02274-X","volume":"297","author":"EB Neufeld","year":"2002","unstructured":"Neufeld EB, Demosky SJ Jr., Stonik JA, Combs C, Remaley AT, Duverger N, et al. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem Biophys Res Commun. 2002;297(4):974\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2639_CR61","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1152\/physrev.00005.2005","volume":"85","author":"JF Oram","year":"2005","unstructured":"Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 2005;85(4):1343\u201372.","journal-title":"Physiol Rev"},{"issue":"1","key":"2639_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/01.ATV.0000194291.94269.5a","volume":"26","author":"LK Curtiss","year":"2006","unstructured":"Curtiss LK, Valenta DT, Hime NJ, Rye KA. What is so special about Apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol. 2006;26(1):12\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2639_CR63","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/ptr.6991","volume":"35","author":"S Soltani","year":"2021","unstructured":"Soltani S, Boozari M, Cicero AFG, Jamialahmadi T, Sahebkar A. Effects of phytochemicals on macrophage cholesterol efflux capacity: impact on atherosclerosis. Phytother Res. 2021;35(6):2854\u201378.","journal-title":"Phytother Res"},{"key":"2639_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","volume":"224","author":"VI Zannis","year":"2015","unstructured":"Zannis VI, Fotakis P, Koukos G, Kardassis D, Ehnholm C, Jauhiainen M, et al. HDL biogenesis, remodeling, and catabolism. Handb Exp Pharmacol. 2015;224:53\u2013111.","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"2639_CR65","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0026-0495(97)90180-3","volume":"46","author":"L Elkhalil","year":"1997","unstructured":"Elkhalil L, Majd Z, Bakir R, Perez-Mendez O, Castro G, Poulain P, et al. Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins. Metabolism. 1997;46(5):474\u201383.","journal-title":"Metabolism"},{"key":"2639_CR66","unstructured":"Bailey A, Mohiuddin SS, Biochemistry. High density lipoprotein. StatPearls. Treasure Island (FL): StatPearls publishing copyright \u00a9 2022. StatPearls Publishing LLC.; 2022."},{"issue":"2","key":"2639_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/ATVBAHA.108.178681","volume":"29","author":"A Jahangiri","year":"2009","unstructured":"Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, Webb NR, et al. HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol. 2009;29(2):261\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2639_CR68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","volume-title":"HDL biogenesis, remodeling, and catabolism. High density lipoproteins: from biological Understanding to clinical exploitation","author":"VI Zannis","year":"2015","unstructured":"Zannis VI, Fotakis P, Koukos G, Kardassis D, Ehnholm C, Jauhiainen M, et al. HDL biogenesis, remodeling, and catabolism. High density lipoproteins: from biological Understanding to clinical exploitation. Cham: Springer International Publishing; 2015. pp. 53\u2013111."},{"issue":"5","key":"2639_CR69","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/138945011795378522","volume":"12","author":"D Ye","year":"2011","unstructured":"Ye D, Lammers B, Zhao Y, Meurs I, Van Berkel TJ, Van Eck M. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Curr Drug Targets. 2011;12(5):647\u201360.","journal-title":"Curr Drug Targets"},{"issue":"3","key":"2639_CR70","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/pr.58.3.1","volume":"58","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006;58(3):342\u201374.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"2639_CR71","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/ATVBAHA.108.179226","volume":"30","author":"D Smith Jonathan","year":"2010","unstructured":"Smith Jonathan D. Dysfunctional HDL as a diagnostic and therapeutic target. Arterioscler Thromb Vasc Biol. 2010;30(2):151\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"44","key":"2639_CR72","doi-asserted-by":"publisher","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","volume":"274","author":"N Xu","year":"1999","unstructured":"Xu N, Dahlback B. A novel human Apolipoprotein (apoM). J Biol Chem. 1999;274(44):31286\u201390.","journal-title":"J Biol Chem"},{"issue":"6","key":"2639_CR73","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0022-2275(20)37337-5","volume":"22","author":"G Bittilo Bon","year":"1981","unstructured":"Bittilo Bon G, Cazzolato G, Avogaro P. Preparative isotachophoresis of human plasma high density lipoproteins HDL2 and HDL3. J Lipid Res. 1981;22(6):998\u20131002.","journal-title":"J Lipid Res"},{"key":"2639_CR74","doi-asserted-by":"crossref","unstructured":"Cockerill GW, Rye K-A, Gamble JR, Vadas MA, Barter PJ, Arteriosclerosis. Thromb Vascular Biology. 1995;15(11):1987\u201394.","DOI":"10.1161\/01.ATV.15.11.1987"},{"issue":"2","key":"2639_CR75","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","volume":"170","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170(2):191\u2013203.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2639_CR76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2016.10.013","volume":"25","author":"EPC van der Vorst","year":"2017","unstructured":"van der Vorst EPC, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, et al. High-Density lipoproteins exert Pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-\u03baB\/STAT1-IRF1 signaling. Cell Metab. 2017;25(1):197\u2013207.","journal-title":"Cell Metab"},{"issue":"2","key":"2639_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/1479164112454309","volume":"10","author":"NN Younis","year":"2013","unstructured":"Younis NN, Soran H, Charlton-Menys V, Sharma R, Hama S, Pemberton P, et al. High-density lipoprotein impedes glycation of low-density lipoprotein. Diab Vasc Dis Res. 2013;10(2):152\u201360.","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"2639_CR78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbalip.2005.09.004","volume":"1737","author":"K Wehmeier","year":"2005","unstructured":"Wehmeier K, Beers A, Haas MJ, Wong NC, Steinmeyer A, Zugel U, et al. Inhibition of Apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3. Biochim Biophys Acta. 2005;1737(1):16\u201326.","journal-title":"Biochim Biophys Acta"},{"key":"2639_CR79","doi-asserted-by":"publisher","first-page":"109472","DOI":"10.1016\/j.jnutbio.2023.109472","volume":"123","author":"H Mousa","year":"2024","unstructured":"Mousa H, Al Saei A, Razali RM, Zughaier SM. Vitamin D status affects proteomic profile of HDL-associated proteins and inflammatory mediators in dyslipidemia. J Nutr Biochem. 2024;123:109472.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"2639_CR80","doi-asserted-by":"publisher","first-page":"e3311","DOI":"10.5812\/ijp.3311","volume":"26","author":"F Tavakoli","year":"2016","unstructured":"Tavakoli F, Namakin K, Zardast M, Vitamin D. Supplementation and High-Density lipoprotein cholesterol: A study in healthy school children. Iran J Pediatr. 2016;26(4):e3311.","journal-title":"Iran J Pediatr"},{"key":"2639_CR81","doi-asserted-by":"crossref","unstructured":"Schumacher T, Benndorf RA. ABC transport proteins in cardiovascular Disease-A brief summary. Molecules. 2017;22(4).","DOI":"10.3390\/molecules22040589"},{"issue":"11","key":"2639_CR82","doi-asserted-by":"publisher","first-page":"777","DOI":"10.14348\/molcells.2014.0265","volume":"37","author":"H Mabuchi","year":"2014","unstructured":"Mabuchi H, Nohara A, Inazu A. Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors. Mol Cells. 2014;37(11):777\u201384.","journal-title":"Mol Cells"},{"issue":"7","key":"2639_CR83","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jama.298.7.786","volume":"298","author":"IM Singh","year":"2007","unstructured":"Singh IM, Shishehbor MH, Ansell BJ. High-density lipoprotein as a therapeutic target: a systematic review. JAMA. 2007;298(7):786\u201398.","journal-title":"JAMA"},{"issue":"Suppl","key":"2639_CR84","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0021-9150(97)00310-9","volume":"137","author":"G de Backer","year":"1998","unstructured":"de Backer G, de Bacquer D, Kornitzer M. Epidemiological aspects of high density lipoprotein cholesterol. Atherosclerosis. 1998;137(Suppl):S1\u20136.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2639_CR85","doi-asserted-by":"publisher","first-page":"20714","DOI":"10.1038\/s41598-021-00020-3","volume":"11","author":"C Caselli","year":"2021","unstructured":"Caselli C, De Caterina R, Smit JM, Campolo J, El Mahdiui M, Ragusa R, et al. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. Sci Rep. 2021;11(1):20714.","journal-title":"Sci Rep"},{"key":"2639_CR86","doi-asserted-by":"publisher","first-page":"b92","DOI":"10.1136\/bmj.b92","volume":"338","author":"M Briel","year":"2009","unstructured":"Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;338:b92.","journal-title":"BMJ"},{"issue":"1","key":"2639_CR87","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12872-022-02760-0","volume":"22","author":"P Gao","year":"2022","unstructured":"Gao P, Wen X, Ou Q, Zhang J. Which one of LDL-C \/HDL-C ratio and non-HDL-C can better predict the severity of coronary artery disease in STEMI patients. BMC Cardiovasc Disord. 2022;22(1):318.","journal-title":"BMC Cardiovasc Disord"},{"key":"2639_CR88","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev.bi.57.070188.002445","volume":"57","author":"B Beutler","year":"1988","unstructured":"Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 1988;57:505\u201318.","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"2639_CR89","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of Hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"2639_CR90","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","volume":"33","author":"SW Brubaker","year":"2015","unstructured":"Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015;33:257\u201390.","journal-title":"Annu Rev Immunol"},{"key":"2639_CR91","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","volume":"5","author":"C Vaure","year":"2014","unstructured":"Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316.","journal-title":"Front Immunol"},{"issue":"2","key":"2639_CR92","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","volume":"164","author":"K Ohashi","year":"2000","unstructured":"Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164(2):558\u201361.","journal-title":"J Immunol"},{"issue":"1","key":"2639_CR93","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1369-5274(99)00046-6","volume":"3","author":"B Beutler","year":"2000","unstructured":"Beutler B, Endotoxin. Toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol. 2000;3(1):23\u20138.","journal-title":"Curr Opin Microbiol"},{"issue":"40","key":"2639_CR94","doi-asserted-by":"publisher","first-page":"38188","DOI":"10.1074\/jbc.M306336200","volume":"278","author":"A Morishima","year":"2003","unstructured":"Morishima A, Ohkubo N, Maeda N, Miki T, Mitsuda N. NFkappaB regulates plasma Apolipoprotein A-I and high density lipoprotein cholesterol through Inhibition of peroxisome proliferator-activated receptor alpha. J Biol Chem. 2003;278(40):38188\u201393.","journal-title":"J Biol Chem"},{"issue":"2","key":"2639_CR95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00109-010-0690-6","volume":"89","author":"S Van Linthout","year":"2011","unstructured":"Van Linthout S, Spillmann F, Graiani G, Miteva K, Peng J, Van Craeyveld E, et al. Down-regulation of endothelial TLR4 signalling after Apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med (Berl). 2011;89(2):151\u201360.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"2639_CR96","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/ALN.0000000000003155","volume":"132","author":"S Tanaka","year":"2020","unstructured":"Tanaka S, Gen\u00e8ve C, Zappella N, Yong-Sang J, Planesse C, Louedec L, et al. Reconstituted High-density lipoprotein therapy improves survival in mouse models of Sepsis. Anesthesiology. 2020;132(4):825\u201338.","journal-title":"Anesthesiology"},{"key":"2639_CR97","doi-asserted-by":"crossref","unstructured":"Cheng N, Liang Y, Du X, Ye RD. Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep. 2018;19(10).","DOI":"10.15252\/embr.201745517"},{"key":"2639_CR98","doi-asserted-by":"crossref","unstructured":"Sato M, Ohkawa R, Yoshimoto A, Yano K, Ichimura N, Nishimori M et al. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. Biosci Rep. 2016;36(4).","DOI":"10.1042\/BSR20160075"},{"issue":"1","key":"2639_CR99","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0022-2275(20)38390-5","volume":"30","author":"VG Cabana","year":"1989","unstructured":"Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res. 1989;30(1):39\u201349.","journal-title":"J Lipid Res"},{"issue":"7","key":"2639_CR100","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/01.ATV.0000023228.90866.29","volume":"22","author":"UJ Tietge","year":"2002","unstructured":"Tietge UJ, Maugeais C, Lund-Katz S, Grass D, deBeer FC, Rader DJ. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I Transgenic mice. Arterioscler Thromb Vasc Biol. 2002;22(7):1213\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2639_CR101","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13054-020-02860-3","volume":"24","author":"S Tanaka","year":"2020","unstructured":"Tanaka S, Couret D, Tran-Dinh A, Duranteau J, Montravers P, Schwendeman A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134.","journal-title":"Crit Care"},{"key":"2639_CR102","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","volume":"159","author":"S Nazir","year":"2020","unstructured":"Nazir S, Jankowski V, Bender G, Zewinger S, Rye K-A, van der Vorst EPC. Interaction between high-density lipoproteins and inflammation: function matters more than concentration! Adv Drug Deliv Rev. 2020;159:94\u2013119.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"2639_CR103","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1007\/s11033-012-1997-x","volume":"39","author":"EM Kosciuczuk","year":"2012","unstructured":"Kosciuczuk EM, Lisowski P, Jarczak J, Strzalkowska N, Jozwik A, Horbanczuk J, et al. Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep. 2012;39(12):10957\u201370.","journal-title":"Mol Biol Rep"},{"issue":"10","key":"2639_CR104","doi-asserted-by":"publisher","first-page":"e13627","DOI":"10.1371\/journal.pone.0013627","volume":"5","author":"SM Zughaier","year":"2010","unstructured":"Zughaier SM, Svoboda P, Pohl J, Stephens DS, Shafer WM. The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release. PLoS ONE. 2010;5(10):e13627.","journal-title":"PLoS ONE"},{"issue":"4","key":"2639_CR105","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nm0406-388","volume":"12","author":"M Zasloff","year":"2006","unstructured":"Zasloff M. Fighting infections with vitamin D. Nat Med. 2006;12(4):388\u201390.","journal-title":"Nat Med"},{"issue":"6","key":"2639_CR106","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11883-003-0036-8","volume":"5","author":"P Alaupovic","year":"2003","unstructured":"Alaupovic P. The concept of apolipoprotein-defined lipoprotein families and its clinical significance. Curr Atheroscler Rep. 2003;5(6):459\u201367.","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"2639_CR107","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.plipres.2004.05.002","volume":"43","author":"H Saito","year":"2004","unstructured":"Saito H, Lund-Katz S, Phillips MC. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog Lipid Res. 2004;43(4):350\u201380.","journal-title":"Prog Lipid Res"},{"issue":"7","key":"2639_CR108","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/clinchem\/33.7.1163","volume":"33","author":"RH Neary","year":"1987","unstructured":"Neary RH, Gowland E. Stability of free Apolipoprotein A-1 concentration in serum, and its measurement in normal and hyperlipidemic subjects. Clin Chem. 1987;33(7):1163\u20139.","journal-title":"Clin Chem"},{"issue":"7","key":"2639_CR109","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/S0021-9258(17)30252-1","volume":"254","author":"MC Ritter","year":"1979","unstructured":"Ritter MC, Scanu AM. Apolipoprotein A-II and structure of human serum high density lipoproteins. An approach by reassembly techniques. J Biol Chem. 1979;254(7):2517\u201325.","journal-title":"J Biol Chem"},{"issue":"6","key":"2639_CR110","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1194\/jlr.M700024-JLR200","volume":"48","author":"M Westerterp","year":"2007","unstructured":"Westerterp M, Berb\u00e9e JF, Delsing DJ, Jong MC, Gijbels MJ, Dahlmans VE, et al. Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification. J Lipid Res. 2007;48(6):1353\u201361.","journal-title":"J Lipid Res"},{"key":"2639_CR111","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","volume":"267","author":"A Wolska","year":"2017","unstructured":"Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO, et al. Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis. 2017;267:49\u201360.","journal-title":"Atherosclerosis"},{"issue":"13","key":"2639_CR112","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","volume":"137","author":"MK Jensen","year":"2018","unstructured":"Jensen MK, Aroner SA, Mukamal KJ, Furtado JD, Post WS, Tsai MY, et al. High-Density lipoprotein subspecies defined by presence of Apolipoprotein C-III and incident coronary heart disease in four cohorts. Circulation. 2018;137(13):1364\u201373.","journal-title":"Circulation"},{"issue":"5","key":"2639_CR113","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1742-1241.2007.01678.x","volume":"62","author":"DC Chan","year":"2008","unstructured":"Chan DC, Chen MM, Ooi EM, Watts GF. An ABC of Apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Int J Clin Pract. 2008;62(5):799\u2013809.","journal-title":"Int J Clin Pract"},{"key":"2639_CR114","doi-asserted-by":"crossref","unstructured":"Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, et al. Apolipoprotein D Biochim Biophys Acta. 2000;1482(1\u20132):185\u201398.","DOI":"10.1016\/S0167-4838(00)00162-X"},{"issue":"2","key":"2639_CR115","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0005-2760(83)90047-4","volume":"750","author":"YL Marcel","year":"1983","unstructured":"Marcel YL, Vezina C, Milne RW. Cholesteryl ester and Apolipoprotein E transfer between human high density lipoproteins and chylomicrons. Biochim Biophys Acta. 1983;750(2):411\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2639_CR116","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/ATVBAHA.116.308435","volume":"37","author":"M Ruiz","year":"2017","unstructured":"Ruiz M, Frej C, Holm\u00e9r A, Guo Li J, Tran S, Dahlb\u00e4ck B. High-Density Lipoprotein\u2013Associated Apolipoprotein M limits endothelial inflammation by delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate receptor 1. Arterioscler Thromb Vasc Biol. 2017;37(1):118\u201329.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2639_CR117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2011.11.031","volume":"221","author":"S Els\u00f8e","year":"2012","unstructured":"Els\u00f8e S, Ahnstr\u00f6m J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, et al. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis. 2012;221(1):91\u20137.","journal-title":"Atherosclerosis"},{"issue":"41","key":"2639_CR118","doi-asserted-by":"publisher","first-page":"25576","DOI":"10.1074\/jbc.272.41.25576","volume":"272","author":"PN Duchateau","year":"1997","unstructured":"Duchateau PN, Pullinger CR, Orellana RE, Kunitake ST, Naya-Vigne J, O\u2019Connor PM, et al. Apolipoprotein L, a new human high density lipoprotein Apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of Apolipoprotein L. J Biol Chem. 1997;272(41):25576\u201382.","journal-title":"J Biol Chem"},{"issue":"2","key":"2639_CR119","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","volume":"61","author":"T Nuutinen","year":"2009","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A, Clusterin. A forgotten player in alzheimer\u2019s disease. Brain Res Rev. 2009;61(2):89\u2013104.","journal-title":"Brain Res Rev"},{"issue":"1","key":"2639_CR120","doi-asserted-by":"publisher","first-page":"14637","DOI":"10.1038\/s41598-017-15215-w","volume":"7","author":"S Fern\u00e1ndez-de-Retana","year":"2017","unstructured":"Fern\u00e1ndez-de-Retana S, Cano-Sarabia M, Marazuela P, S\u00e1nchez-Quesada JL, Garcia-Leon A, Monta\u00f1ola A, et al. Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral \u03b2-amyloidosis. Sci Rep. 2017;7(1):14637.","journal-title":"Sci Rep"},{"issue":"14","key":"2639_CR121","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.1074\/jbc.M110.209130","volume":"286","author":"Z Wu","year":"2011","unstructured":"Wu Z, Gogonea V, Lee X, May RP, Pipich V, Wagner MA, et al. The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering. J Biol Chem. 2011;286(14):12495\u2013508.","journal-title":"J Biol Chem"},{"issue":"25","key":"2639_CR122","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2174\/0929867321666140303153430","volume":"21","author":"D Kardassis","year":"2014","unstructured":"Kardassis D, Mosialou I, Kanaki M, Tiniakou I, Thymiakou E. Metabolism of HDL and its regulation. Curr Med Chem. 2014;21(25):2864\u201380.","journal-title":"Curr Med Chem"},{"issue":"5","key":"2639_CR123","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1194\/jlr.M700506-JLR200","volume":"49","author":"PT Duong","year":"2008","unstructured":"Duong PT, Weibel GL, Lund-Katz S, Rothblat GH, Phillips MC. Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I. J Lipid Res. 2008;49(5):1006\u201314.","journal-title":"J Lipid Res"},{"key":"2639_CR124","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cca.2020.02.025","volume":"505","author":"W Chen","year":"2020","unstructured":"Chen W, Wu Y, Lu Q, Wang S, Xing D. Endogenous ApoA-I expression in macrophages: A potential target for protection against atherosclerosis. Clin Chim Acta. 2020;505:55\u20139.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"2639_CR125","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1161\/ATVBAHA.110.211342","volume":"30","author":"CA Bursill","year":"2010","unstructured":"Bursill CA, Castro ML, Beattie DT, Nakhla S, van der Vorst E, Heather AK, et al. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2010;30(9):1773\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2639_CR126","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2784","volume":"15","author":"D De Nardo","year":"2014","unstructured":"De Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat Immunol. 2014;15(2):152\u201360.","journal-title":"Nat Immunol"},{"key":"2639_CR127","doi-asserted-by":"crossref","unstructured":"Iqbal AJ, Barrett TJ, Taylor L, McNeill E, Manmadhan A, Recio C et al. Acute exposure to Apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo. Elife. 2016;5.","DOI":"10.7554\/eLife.15190"},{"issue":"6","key":"2639_CR128","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","volume":"1","author":"WC Cromwell","year":"2007","unstructured":"Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, et al. LDL particle number and risk of future cardiovascular disease in the Framingham offspring Study - Implications for LDL management. J Clin Lipidol. 2007;1(6):583\u201392.","journal-title":"J Clin Lipidol"},{"issue":"3","key":"2639_CR129","doi-asserted-by":"publisher","first-page":"190","DOI":"10.34172\/jcvtr.2021.21","volume":"13","author":"N Radkhah","year":"2021","unstructured":"Radkhah N, Shabbidar S, Zarezadeh M, Safaeiyan A, Barzegar A. Effects of vitamin D supplementation on Apolipoprotein A1 and B100 levels in adults: systematic review and meta-analysis of controlled clinical trials. J Cardiovasc Thorac Res. 2021;13(3):190\u20137.","journal-title":"J Cardiovasc Thorac Res"},{"key":"2639_CR130","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-981-15-6082-8_7","volume":"1276","author":"G Luo","year":"2020","unstructured":"Luo G, Xu N, Apolipoprotein M. Research progress and clinical perspective. Adv Exp Med Biol. 2020;1276:85\u2013103.","journal-title":"Adv Exp Med Biol"},{"issue":"Pt 1","key":"2639_CR131","first-page":"1","volume":"318","author":"DR Flower","year":"1996","unstructured":"Flower DR. The Lipocalin protein family: structure and function. Biochem J. 1996;318(Pt 1):1\u201314. (Pt 1)(.","journal-title":"Biochem J"},{"issue":"18","key":"2639_CR132","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1128\/MCB.00579-06","volume":"26","author":"N Venteclef","year":"2006","unstructured":"Venteclef N, Smith JC, Goodwin B, Delerive P. Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. Mol Cell Biol. 2006;26(18):6799\u2013807.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2639_CR133","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tem.2008.11.003","volume":"20","author":"LB Nielsen","year":"2009","unstructured":"Nielsen LB, Christoffersen C, Ahnstrom J, Dahlback B. ApoM: gene regulation and effects on HDL metabolism. Trends Endocrinol Metab. 2009;20(2):66\u201371.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"2639_CR134","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jmb.2009.08.071","volume":"393","author":"M Sevvana","year":"2009","unstructured":"Sevvana M, Ahnstrom J, Egerer-Sieber C, Lange HA, Dahlback B, Muller YA. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in Apolipoprotein M. J Mol Biol. 2009;393(4):920\u201336.","journal-title":"J Mol Biol"},{"issue":"5","key":"2639_CR135","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","volume":"130","author":"HM Kim","year":"2007","unstructured":"Kim HM, Park BS, Kim J-I, Kim SE, Lee J, Oh SC, et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007;130(5):906\u201317.","journal-title":"Cell"},{"issue":"2","key":"2639_CR136","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3892\/mmr.2015.3658","volume":"12","author":"LZ Huang","year":"2015","unstructured":"Huang LZ, Gao JL, Pu C, Zhang PH, Wang LZ, Feng G, et al. Apolipoprotein M: research progress, regulation and metabolic functions (Review). Mol Med Rep. 2015;12(2):1617\u201324.","journal-title":"Mol Med Rep"},{"issue":"27","key":"2639_CR137","doi-asserted-by":"publisher","first-page":"18765","DOI":"10.1074\/jbc.M800695200","volume":"283","author":"C Christoffersen","year":"2008","unstructured":"Christoffersen C, Ahnstr\u00f6m J, Axler O, Christensen EI, Dahlb\u00e4ck B, Nielsen LB. The signal peptide anchors Apolipoprotein M in plasma lipoproteins and prevents rapid clearance of Apolipoprotein M from plasma*. J Biol Chem. 2008;283(27):18765\u201372.","journal-title":"J Biol Chem"},{"key":"2639_CR138","first-page":"101445","volume":"34","author":"H Mousa","year":"2023","unstructured":"Mousa H, Thanassoulas A, Zughaier SM. ApoM binds endotoxin contributing to neutralization and clearance by high density lipoprotein. Biochem Biophys Rep. 2023;34:101445.","journal-title":"Biochem Biophys Rep"},{"key":"2639_CR139","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-05879-5_4","volume-title":"Sphingosine-1-Phosphate signaling in immunology and infectious diseases","author":"Y Xiong","year":"2014","unstructured":"Xiong Y, Hla T. S1P control of endothelial integrity. In: Oldstone MBA, Rosen H, editors. Sphingosine-1-Phosphate signaling in immunology and infectious diseases. Cham: Springer International Publishing; 2014. pp. 85\u2013105."},{"issue":"3","key":"2639_CR140","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/bph.12174","volume":"169","author":"A Tran-Dinh","year":"2013","unstructured":"Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B, et al. HDL and endothelial protection. Br J Pharmacol. 2013;169(3):493\u2013511.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2639_CR141","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/cvr\/cvu136","volume":"103","author":"F Pot\u00ec","year":"2014","unstructured":"Pot\u00ec F, Simoni M, Nofer JR. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). Cardiovasc Res. 2014;103(3):395\u2013404.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2639_CR142","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10753-018-0918-0","volume":"42","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Zeng Y, Zhu X, Tan Y, Li Y, Li Q, et al. ApoM-S1P modulates Ox-LDL-Induced inflammation through the PI3K\/Akt signaling pathway in HUVECs. Inflammation. 2019;42(2):606\u201317.","journal-title":"Inflammation"},{"issue":"1","key":"2639_CR143","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40560-019-0376-2","volume":"7","author":"MS Winkler","year":"2019","unstructured":"Winkler MS, M\u00e4rtz KB, Nierhaus A, Daum G, Schwedhelm E, Kluge S, et al. Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL). J Intensive Care. 2019;7(1):23.","journal-title":"J Intensive Care"},{"issue":"1","key":"2639_CR144","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/CIRCRESAHA.112.280081","volume":"112","author":"S Saddar","year":"2013","unstructured":"Saddar S, Carriere V, Lee W-R, Tanigaki K, Yuhanna IS, Parathath S, et al. Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circul Res. 2013;112(1):140\u201351.","journal-title":"Circul Res"},{"key":"2639_CR145","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2021.08.039","volume":"334","author":"I Yao Mattisson","year":"2021","unstructured":"Yao Mattisson I, Christoffersen C. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system. Atherosclerosis. 2021;334:76\u201384.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2639_CR146","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12944-016-0325-1","volume":"15","author":"P Zhang","year":"2016","unstructured":"Zhang P, Gao J, Pu C, Feng G, Wang L, Huang L, et al. Effects of hyperlipidaemia on plasma Apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study. Lipids Health Dis. 2016;15(1):158.","journal-title":"Lipids Health Dis"},{"issue":"18","key":"2639_CR147","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.119.045323","volume":"141","author":"JA Chirinos","year":"2020","unstructured":"Chirinos JA, Zhao L, Jia Y, Frej C, Adamo L, Mann D, et al. Reduced Apolipoprotein M and adverse outcomes across the spectrum of human heart failure. Circulation. 2020;141(18):1463\u201376.","journal-title":"Circulation"},{"issue":"8","key":"2639_CR148","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2337\/db21-0920","volume":"71","author":"NL Baker","year":"2022","unstructured":"Baker NL, Hammad SM, Hunt KJ, Semler A, Klein RL, Lopes-Virella MF. Plasma ApoM levels and progression to kidney dysfunction in patients with type 1 diabetes. Diabetes. 2022;71(8):1795\u20139.","journal-title":"Diabetes"},{"issue":"4","key":"2639_CR149","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7150\/ijms.7696","volume":"11","author":"L Zheng","year":"2014","unstructured":"Zheng L, Luo G, Zhang J, Mu Q, Shi Y, Berggren-S\u00f6derlund M, et al. Decreased activities of Apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases. Int J Med Sci. 2014;11(4):365\u201372.","journal-title":"Int J Med Sci"},{"issue":"1","key":"2639_CR150","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.celrep.2017.12.029","volume":"22","author":"C Christoffersen","year":"2018","unstructured":"Christoffersen C, Federspiel CK, Borup A, Christensen PM, Madsen AN, Heine M, et al. The Apolipoprotein M\/S1P Axis controls triglyceride metabolism and brown fat activity. Cell Rep. 2018;22(1):175\u201388.","journal-title":"Cell Rep"},{"issue":"9","key":"2639_CR151","first-page":"158969","volume":"1866","author":"S Hajny","year":"2021","unstructured":"Hajny S, Borup A, Els\u00f8e S, Christoffersen C. Increased plasma ApoM levels impair triglyceride turnover in mice. Biochim Et Biophys Acta (BBA) - Mol Cell Biology Lipids. 2021;1866(9):158969.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Cell Biology Lipids"},{"issue":"2","key":"2639_CR152","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3892\/mmr.2017.6716","volume":"16","author":"MM Yu","year":"2017","unstructured":"Yu MM, Yao S, Luo KM, Mu QF, Yu Y, Luo GH, et al. Apolipoprotein M increases the expression of vitamin D receptor mRNA in colorectal cancer cells detected with duplex fluorescence reverse transcription-quantitative polymerase chain reaction. Mol Med Rep. 2017;16(2):1167\u201372.","journal-title":"Mol Med Rep"},{"issue":"42","key":"2639_CR153","doi-asserted-by":"publisher","first-page":"31068","DOI":"10.1074\/jbc.M703552200","volume":"282","author":"A Eichinger","year":"2007","unstructured":"Eichinger A, Nasreen A, Kim HJ, Skerra A. Structural insight into the dual ligand specificity and mode of high density lipoprotein association of Apolipoprotein D. J Biol Chem. 2007;282(42):31068\u201375.","journal-title":"J Biol Chem"},{"issue":"2","key":"2639_CR154","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4161\/cc.9.2.10433","volume":"9","author":"J Muffat","year":"2010","unstructured":"Muffat J, Walker DW, Apolipoprotein D. An overview of its role in aging and age-related diseases. Cell Cycle. 2010;9(2):269\u201373.","journal-title":"Cell Cycle"},{"issue":"4","key":"2639_CR155","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1046\/j.1471-4159.1998.71041643.x","volume":"71","author":"L Terrisse","year":"1998","unstructured":"Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, et al. Increased levels of Apolipoprotein D in cerebrospinal fluid and hippocampus of alzheimer\u2019s patients. J Neurochem. 1998;71(4):1643\u201350.","journal-title":"J Neurochem"},{"issue":"2","key":"2639_CR156","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0006-3223(02)01976-5","volume":"54","author":"EA Thomas","year":"2003","unstructured":"Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, et al. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with alzheimer\u2019s disease: no relation to Apolipoprotein E expression or genotype. Biol Psychiatry. 2003;54(2):136\u201341.","journal-title":"Biol Psychiatry"},{"issue":"41","key":"2639_CR157","doi-asserted-by":"publisher","first-page":"10330","DOI":"10.1523\/JNEUROSCI.2644-08.2008","volume":"28","author":"S Do Carmo","year":"2008","unstructured":"Do Carmo S, Jacomy H, Talbot PJ, Rassart E. Neuroprotective effect of Apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci. 2008;28(41):10330\u20138.","journal-title":"J Neurosci"},{"issue":"18","key":"2639_CR158","first-page":"4091","volume":"57","author":"YS Lopez-Boado","year":"1997","unstructured":"Lopez-Boado YS, Puente XS, Alvarez S, Tolivia J, Binderup L, Lopez-Otin C. Growth Inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of Apolipoprotein D expression. Cancer Res. 1997;57(18):4091\u20137.","journal-title":"Cancer Res"},{"key":"2639_CR159","doi-asserted-by":"crossref","unstructured":"Darwish NM, Al-Hail MK, Mohamed Y, Al Saady R, Mohsen S, Zar A et al. The role of apolipoproteins in the commonest cancers: A review. Cancers (Basel). 2023;15(23).","DOI":"10.3390\/cancers15235565"},{"issue":"3","key":"2639_CR160","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jsbmb.2009.01.003","volume":"113","author":"J-H Wang","year":"2009","unstructured":"Wang J-H, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P. Serum cholesterol and expression of apoai, LXR\u03b2 and SREBP2 in vitamin D receptor knock-out mice. J Steroid Biochem Mol Biol. 2009;113(3):222\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"2639_CR161","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.nutres.2011.09.005","volume":"31","author":"S Jaimungal","year":"2011","unstructured":"Jaimungal S, Wehmeier K, Mooradian AD, Haas MJ. The emerging evidence for vitamin D\u2013mediated regulation of Apolipoprotein A-I synthesis. Nutr Res. 2011;31(11):805\u201312.","journal-title":"Nutr Res"},{"issue":"null","key":"2639_CR162","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/CMAR.S202799","volume":"11","author":"M Yu","year":"2019","unstructured":"Yu M, Lili P, Chen S, Qinfeng M, Lu Z, Guanghua L, et al. Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling. Cancer Manage Res. 2019;11(null):3691\u2013701.","journal-title":"Cancer Manage Res"},{"issue":"1","key":"2639_CR163","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12944-017-0476-8","volume":"16","author":"W Du","year":"2017","unstructured":"Du W, Shen T, Li H, Liu Y, He L, Tan L, et al. Low Apolipoprotein M serum levels correlate with systemic lupus erythematosus disease activity and Apolipoprotein M gene polymorphisms with lupus. Lipids Health Dis. 2017;16(1):88.","journal-title":"Lipids Health Dis"},{"key":"2639_CR164","doi-asserted-by":"crossref","unstructured":"Hajny S, Christoffersen M, Dalila N, Nielsen LB, Tybj\u00e6rg-Hansen A, Christoffersen C. Apolipoprotein M and risk of type 2 diabetes. J Clin Endocrinol Metab. 2020;105(9).","DOI":"10.1210\/clinem\/dgaa433"},{"issue":"16","key":"2639_CR165","first-page":"4336","volume":"51","author":"J Simard","year":"1991","unstructured":"Simard J, Veilleux R, de Launoit Y, Haagensen DE, Labrie F. Stimulation of Apolipoprotein D secretion by steroids coincides with Inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res. 1991;51(16):4336\u201341.","journal-title":"Cancer Res"},{"issue":"5","key":"2639_CR166","first-page":"972","volume":"9","author":"I Nagaoka","year":"2002","unstructured":"Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, et al. Augmentation of the lipopolysaccharide-neutralizing activities of human Cathelicidin CAP18\/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol. 2002;9(5):972\u201382.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"2639_CR167","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.4049\/jimmunol.1602164","volume":"199","author":"M Coorens","year":"2017","unstructured":"Coorens M, Schneider VAF, de Groot AM, van Dijk A, Meijerink M, Wells JM, et al. Cathelicidins inhibit Escherichia coli-Induced TLR2 and TLR4 activation in a Viability-Dependent manner. J Immunol. 2017;199(4):1418\u201328.","journal-title":"J Immunol"},{"issue":"1","key":"2639_CR168","doi-asserted-by":"publisher","first-page":"e85765","DOI":"10.1371\/journal.pone.0085765","volume":"9","author":"Z Hu","year":"2014","unstructured":"Hu Z, Murakami T, Suzuki K, Tamura H, Kuwahara-Arai K, Iba T, et al. Antimicrobial Cathelicidin peptide LL-37 inhibits the LPS\/ATP-induced pyroptosis of macrophages by dual mechanism. PLoS ONE. 2014;9(1):e85765.","journal-title":"PLoS ONE"},{"issue":"32","key":"2639_CR169","doi-asserted-by":"publisher","first-page":"22445","DOI":"10.1074\/jbc.274.32.22445","volume":"274","author":"O Sorensen","year":"1999","unstructured":"Sorensen O, Bratt T, Johnsen AH, Madsen MT, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J Biol Chem. 1999;274(32):22445\u201351.","journal-title":"J Biol Chem"},{"issue":"6","key":"2639_CR170","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3897\/folmed.63.e62417","volume":"63","author":"ZF Sharba","year":"2021","unstructured":"Sharba ZF, Shareef RH, Abd BA, Hameed EN. Association between dyslipidemia and vitamin D deficiency: a Cross-Sectional study. Folia Med (Plovdiv). 2021;63(6):965\u20139.","journal-title":"Folia Med (Plovdiv)"},{"key":"2639_CR171","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/nu15214575","volume":"15","author":"R MacGirlley","year":"2023","unstructured":"MacGirlley R, Phoswa WN, Mokgalaboni K. Modulatory properties of vitamin D in type 2 diabetic patients: A focus on inflammation and dyslipidemia. Nutrients. 2023;15:21.","journal-title":"Nutrients"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02639-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:05:33Z","timestamp":1757329533000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02639-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":171,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2639"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02639-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"257"}}